PATENT CLAIM ANALYSIS

Application Number: 15766011
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["564", "401000"]

Abstract:
The invention relates to novel compounds that are useful for modulating cellular ROS. The compounds are amide-derivatives of 2-hydroxy-2-methyl-4-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-butanoic acid. The compounds of the invention are formulated into pharmaceutical or cosmetic compositions. The invention further relates to methods wherein the compounds of the invention are used for treating or preventing diseases associated with increased ROS levels mitochondrial disorders and/or conditions associated with mitochondrial dysfunction, including adverse drug effects. The invention also relates to cosmetic methods for treating or delaying further aging of the skin and veterinary applications.

Claim (Index 31):
A pharmaceutical or cosmetic composition comprising a compound according to  claim 23  and a physiologically acceptable carrier.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 91.0
- Lexical Diversity: 1.70175
- Patent Class: 564.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14414055', '15442475', '15550273', '15037941', '15502330']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6579212743591569
- 35 USC 102 Novelty (BERT): 0.5575960784864818
- Combined Prediction Score: 0.6478887547718895
- Mean Citation Score: 246.22474000000005
- Max Citation Score: 380.35
- Similarity Product: 273.12512257993217

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test